IBD Ventures
IBD Ventures funds product-focused research to develop new therapies, diagnostics, or technologies that address unmet needs for patients with Crohn's disease and ulcerative colitis.
Funder: Crohn's and Colitis Foundation
Due Dates: September 18, 2026: Letter of Intent deadline (IBD Ventures)
Funding Amounts: Up to $500,000 per project per year; typical duration is 12 months, with potential for renewal if milestones are met.
Summary: Supports the development of novel products to improve the quality of life for patients with inflammatory bowel diseases, offering funding plus accelerator resources and advising.
Description
IBD Ventures is a funding program from the Crohn's & Colitis Foundation designed to accelerate the discovery and development of new products that address unmet needs for patients living with inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis. The initiative supports both for-profit companies and academic groups engaged in product-oriented research, providing not only financial support but also access to accelerator resources, strategic advising, and networking opportunities. Projects must be focused on advancing a specific product (therapeutic, diagnostic, device, software, or service) with clear potential to benefit IBD patients.
